Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
HIV Med ; 24(7): 845-850, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36895110

RESUMO

OBJECTIVES: In response to the COVID-19 pandemic, HIV outpatient attendances were restricted from March 2020, resulting in reduced frequency of HIV viral load (VL) monitoring (previously 6-monthly) in clinically stable and virologically suppressed people living with HIV (PLWH). We investigated virological outcomes during this period of reduced monitoring and compared with the previous year, prior to the COVID-19 pandemic. METHODS: People living with HIV with undetectable VL (<200 HIV RNA copies /mL) on antiretroviral therapy (ART) were identified from March 2018 to February 2019. We determined VL outcomes during the pre-COVD-19 period (March 2019-February 2020) and the COVID-19 period (March 2020-February 2021) when monitoring was restricted. Frequency and longest durations between VL tests in each period were evaluated, and virological sequelae in those with detectable VL were determined. RESULTS: Of 2677 PLWH virologically suppressed on ART (March 2018-February 2019), VLs were measured and undetectable in 2571 (96.0%) and 2003 (77.9%) in the pre-COVID and COVID periods, respectively. Mean (SD) numbers of VL tests were 2.3 (1.08) and 1.1 (0.83) and mean longest duration between VL tests was 29.5 weeks (SD 8.25, 3.1% were ≥12 months) and 43.7 weeks (12.64, 28.4% were ≥12 months), in the pre-COVID and COVID periods, respectively. Of 45 individuals with one or more detectable VL during the COVID-19 period, two developed new drug resistance mutations. CONCLUSION: Reduced VL monitoring was not associated with poorer virological outcomes in the majority of stable individuals receiving ART. One in 20 individuals had not returned for VL testing after ≥31 months and the risk of harm in these individuals is unknown.


Assuntos
Fármacos Anti-HIV , COVID-19 , Infecções por HIV , Humanos , Infecções por HIV/tratamento farmacológico , Carga Viral , Pandemias , Progressão da Doença , Fármacos Anti-HIV/uso terapêutico
2.
HIV Med ; 22(2): 146-150, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33151034

RESUMO

OBJECTIVES: As people with HIV (PWH) age, the prevalence of frailty increases. Rapid screening tests to identify frailty within HIV outpatient settings are required to identify at-risk individuals. We undertook a service evaluation to assess three short frailty assessments in PWH. METHODS: We assessed two objective [gait speed (GS), timed-up-and-go test (TUGT)] and one subjective [the self-reported health questionnaire (SRH)] frailty screening tools in PWH aged > 40 years attending a single HIV outpatient department. Factors associated with positive frailty screening tests (defined as GS < 0.8 m/s, TUGT ≥ 10 s and SRH score < 6) were assessed using logistic regression models. ETHICAL CONSIDERATIONS: This was a service evaluation and was approved as a service evaluation by the Imperial College Healthcare NHS trust HIV clinical research committee (February 2020). All participants were given verbal information and were able to terminate the screening tests at any time. RESULTS: Of 84 PWH approached, 80 individuals completed all screening tests (median age = 56 years, range: 40-80) with a positive frailty screening prevalence in 19%, 33% and 20% for GS, TUGT and SRH, respectively. All tests were considered acceptable to participants. Factors statistically significantly associated with frailty included age (GS and TUGT), detectable HIV RNA (TUGT), number of comorbidities (GS and TUGT), presence of polypharmacy (GS and TUGT) and total number of concomitant medication (GS and SRH). CONCLUSIONS: Rates of positive screening tests for frailty are dependent on screening tool used, with all three tools being acceptable to participants. Objective measures of frailty screening (GS and TUGT) are more closely associated with clinical parameters than is a subjective measure of frailty screening (SRH).


Assuntos
Fragilidade , Infecções por HIV , Adulto , Fragilidade/diagnóstico , Fragilidade/epidemiologia , Infecções por HIV/complicações , Infecções por HIV/diagnóstico , Humanos , Programas de Rastreamento , Pessoa de Meia-Idade , Equilíbrio Postural , Estudos de Tempo e Movimento
3.
HIV Med ; 21(2): 109-118, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31617962

RESUMO

OBJECTIVES: Persistent CD4:CD8 ratio inversion (< 1) is associated with mortality in older people. We investigated the interaction of the effects of baseline CD8 count and age at HIV diagnosis on CD4:CD8 ratio recovery with antiretroviral therapy (ART). METHODS: An observational study (1 January 2007 to 31 December 2016) was carried out using routinely collected data from the HIV outpatient services at Imperial College Healthcare NHS Trust, London, UK. CD4 and CD8 counts, prior to and during ART, treatment during primary HIV infection (PHI) and HIV-1 viral load were included in univariate and multivariate analyses using Cox proportional hazard regression. RESULTS: Data were included for 876 patients starting ART, where HIV suppression was achieved. Of these patients, 741 of 876 (84.6%) were male and 507 of 876 (57.9%) were Caucasian. The median time on ART was 38 [interquartile range (IQR) 17-66] months. CD8 count change on ART was bidirectional; low CD8 counts (≤ 600 cells/µL) increased and high CD8 counts (> 900 cells/µL) decreased. The median pre-ART CD4:CD8 ratio was 0.41 (IQR 0.24-0.63), and recovery (≥ 1) occurred in 274 of 876 patients (31.3%). Pre- and post-ART CD4:CD8 ratios were lower in those aged > 50 years compared with young adults aged 18-30 years (P < 0.001 and P = 0.002, respectively). After adjustment, younger age at HIV diagnosis (P < 0.001) and treatment during PHI (P < 0.001) were favourable for CD4:CD8 ratio normalization. CONCLUSIONS: Older age (> 50 years) at HIV diagnosis was associated with persistent CD4:CD8 ratio inversion, whereas treatment of PHI was protective. These findings confirm the need for testing and early treatment of people aged > 50 years, and could be used in a risk management algorithm for enhanced surveillance.


Assuntos
Antirretrovirais/uso terapêutico , Infecções por HIV/tratamento farmacológico , Infecções por HIV/imunologia , HIV-1/genética , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Assistência Ambulatorial , Relação CD4-CD8 , Feminino , Infecções por HIV/virologia , HIV-1/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Reino Unido/etnologia , Carga Viral
4.
HIV Med ; 21(5): 309-321, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-31927793

RESUMO

OBJECTIVES: The aim of the study was to investigate whether lamivudine (3TC) or emtricitabine (FTC) use following detection of M184V/I is associated with better virological outcomes. METHODS: We identified people with viruses harbouring the M184V/I mutation in UK multicentre data sets who had treatment change/initiation within 1 year. We analysed outcomes of viral suppression (< 200 HIV-1 RNA copies/mL) and appearance of new major drug resistance mutations (DRMs) using Cox and Poisson models, with stratification by new drug regimen (excluding 3TC/FTC) and Bayesian implementation, and estimated the effect of 3TC/FTC adjusted for individual and viral characteristics. RESULTS: We included 2597 people with the M184V/I resistance mutation, of whom 665 (25.6%) were on 3TC and 458 (17.6%) on FTC. We found a negative adjusted association between 3TC/FTC use and viral suppression [hazard ratio (HR) 0.84; 95% credibility interval (CrI) 0.71-0.98]. On subgroup analysis of individual drugs, there was no evidence of an association with viral suppression for 3TC (n = 184; HR 0.94; 95% CrI 0.73-1.15) or FTC (n = 454; HR 0.99; 95% CrI 0.80-1.19) amongst those on tenofovir-containing regimens, but we estimated a reduced rate of viral suppression for people on 3TC amongst those without tenofovir use (n = 481; HR 0.71; 95% CrI 0.54-0.90). We found no association between 3TC/FTC and detection of any new DRM (overall HR 0.92; 95% CrI 0.64-1.18), but found inconclusive evidence of a lower incidence rate of new DRMs (overall incidence rate ratio 0.69; 95% CrI 0.34-1.11). CONCLUSIONS: We did not find evidence that 3TC or FTC use is associated with an increase in viral suppression, but it may reduce the appearance of additional DRMs in people with M184V/I. 3TC was associated with reduced viral suppression amongst people on regimens without tenofovir.


Assuntos
Fármacos Anti-HIV/administração & dosagem , Farmacorresistência Viral/efeitos dos fármacos , Emtricitabina/administração & dosagem , Infecções por HIV/tratamento farmacológico , HIV-1/genética , Lamivudina/administração & dosagem , Tenofovir/administração & dosagem , Adulto , Fármacos Anti-HIV/farmacologia , Quimioterapia Combinada , Emtricitabina/farmacologia , Feminino , HIV-1/efeitos dos fármacos , Humanos , Lamivudina/farmacologia , Masculino , Mutação , Tenofovir/farmacologia , Falha de Tratamento , Reino Unido
5.
Infection ; 41(3): 731-4, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23378293

RESUMO

We report the first published case of integrase inhibitor resistance in the central nervous system compartment in the absence of evidence of integrase inhibitor resistance in the plasma of a patient without human immunodeficiency virus (HIV)-encephalitis in the context of other HIV-associated central nervous system infections.


Assuntos
Complexo AIDS Demência/virologia , Fármacos Anti-HIV/farmacologia , Líquido Cefalorraquidiano/virologia , Farmacorresistência Viral , HIV/efeitos dos fármacos , Pirrolidinonas/farmacologia , Complexo AIDS Demência/tratamento farmacológico , Fármacos Anti-HIV/administração & dosagem , Encéfalo/diagnóstico por imagem , HIV/isolamento & purificação , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Plasma/virologia , Pirrolidinonas/administração & dosagem , Radiografia , Raltegravir Potássico
6.
Poult Sci ; 102(4): 102514, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-36805403

RESUMO

For laying hens, the immediate aftermath and healing period of a keel fracture (KF) is characterized by reduced ability to perform species-specific behavior, access resources, and pain. However, the longer-term impacts, once the fracture is completely healed, are less clear. As well as acute pain and behavioral changes, a negative experience can shape future responses to putatively threatening stimuli, raising future fear, and anxiety levels during husbandry-related events. We aimed to determine whether hens that had previously sustained keel bone fractures, but were now outside of the peak age range for new fractures, showed higher fear and anxiety levels compared to intact hens. We also determined if healed keel bone fractures were associated with reduced production, changes in behavior and resource use. One hundred and fifty hens with a palpation score of 1 ( "KF") and 150 hens with a palpation score of 0 (keel fracture free, "KFF") were selected from a commercial farm at 63 wk of age and housed in 6 groups (3 × KF and 3 × KFF). We compared production (hen weight and feed consumption, egg quantity, quality and weight, floor eggs, shell thickness, and weight) and home pen behavior (behaviors and transitional movements) in both groups. Finally, we measured the responses of KF (n = 75) and KFF (n = 75) during tonic immobility, novel arena, and novel object tests. KF and KFF hens did not differ in their responses to the tonic immobility, novel arena, and novel object tests, nor were there differences between the 2 groups in home pen behavior and transitional movements. KFF birds were lighter and laid eggs with less eggshell membrane compared KF birds, but no differences were found between KF and KFF in any other production measures. We found no evidence that healed KFs were associated with detrimental welfare effects in laying hens, but further work is required to determine the mechanisms and implications of the lower body weight and egg shell membrane.


Assuntos
Galinhas , Fraturas Ósseas , Animais , Feminino , Galinhas/fisiologia , Óvulo , Fraturas Ósseas/veterinária , Ansiedade , Medo , Abrigo para Animais
9.
HIV Med ; 10(1): 35-43, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19018876

RESUMO

OBJECTIVE: The aim of this study was to describe the relationship between age and the time to treatment discontinuation in the absence of virological failure as well as the development of specific laboratory abnormalities, in patients starting highly active antiretroviral therapy (HAART) for the first time. METHODS: Analyses included 8708 antiretroviral-naïve patients from the UK Collaborative HIV Cohort (CHIC) study who started HAART from 1998 onwards. We considered time to the first discontinuation of any drug in the initial HAART regimen for reasons other than virological failure; the association between this and age at the start of HAART was determined using proportional hazards regression after adjustment for potential confounders. The incidence of specific laboratory abnormalities in the first year after starting HAART was compared in those of different ages using multiple logistic regression. RESULTS: A total of 2650 patients discontinued at least one drug in their HAART regimen in the first year for reasons other than virological failure; after controlling for confounders, those aged < 30 years at the time of starting HAART were more likely to discontinue than those aged 30-39 years [relative hazard (RH) 1.12; 95% confidence interval (CI) 1.01, 1.24] as were those aged > or = 50 years (RH 1.14; 95% CI 1.00, 1.31). There were strong associations between greater age and raised total cholesterol, decreased haemoglobin and raised triglycerides over the first year, although the latter disappeared after adjustment for pre-HAART levels, suggesting that this finding reflected higher pre-HAART triglyceride levels in older individuals. CONCLUSIONS: Continued attempts to improve the tolerability of HAART regimens may help to sustain the good outcomes in all age groups over the longer term.


Assuntos
Terapia Antirretroviral de Alta Atividade/efeitos adversos , Infecções por HIV/tratamento farmacológico , HIV-1 , Adulto , Fatores Etários , Contagem de Linfócito CD4 , Esquema de Medicação , Feminino , Infecções por HIV/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente , Fatores de Tempo , Carga Viral
10.
Poult Sci ; 103(6): 103678, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38593550
12.
J Virus Erad ; 1(3): 173-8, 2015 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-27482409

RESUMO

OBJECTIVES: Retrospective analysis of evolution of HIV tropism and association with disease progression in perinatal HIV-1 infection (PaHIV). METHODOLOGY: Eligible patients with PaHIV were grouped as slow, rapid or long-term non-progressors (LTNP). The V3 region of gp120 was sequenced from stored plasma samples and tropism determined by geno2pheno algorithm (FPR 5.75%). Logistic regression with generalised estimating equations assessed factors associated with R5 virus. Time to tropism change was assessed using standard survival methods. RESULTS: At baseline (n=48) median age was 12 years (IQR 9.3-14.8), 52% were female, 79% were Black African, 96% were non-B subtypes and 81% (39/48) had R5-using virus. Median follow-up was 7.7 years (308.6 person-years), with a median of five (range 1-14) samples per subject (total 252). Analysing all samples, R5 virus was associated with higher current CD4 cell count (median 520 cells/mm(3) R5 vs 202 for X4, P=0.0005), LTNP (35% vs 11%, P=0.05), non-Black ethnicity (74% vs 89%, P=0.05) and female gender (55% vs 28%, P=0.005). Twelve of 38 (31%) with R5 virus at baseline switched to X4/dual-using virus, with an estimated 5-year risk of switch of 24.4% (95% CI 9.7-39.2%) predicted by lower current CD4 cell count (unadjusted HR 0.62/50 cells higher, 95% CI 0.47-0.81, P=0.0006). Eleven of 19 (58%) with X4/dual-using virus subsequently had R5 virus at one or more time points. CONCLUSION: Maraviroc was a treatment option for 81% at 12 years, falling to 56% at 18 years, with lower CD4 cell count predictive of co-receptor switching. Paediatric studies of CCR5 antagonists should be expedited to ensure they are an early treatment option before tropism switching occurs.

13.
Arch Dis Child ; 100(6): 527-31, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25549664

RESUMO

OBJECTIVE: The objective of this study is to review clinical outcomes of recommendations made by a multidisciplinary paediatric virtual clinic (PVC) for complex case management of paediatric HIV as a model of care within a tertiary network. DESIGN: A retrospective review of the clinical outcomes of paediatric and adolescent (0-21 years) referrals to the PVC at St. Mary's Hospital, Imperial College Healthcare NHS Trust, London was performed between October 2009 and November 2013. RESULTS: 234 referrals were made for 182 children from 37 centres, discussed in 42 meetings (median age 13 years, IQR 10-15 years). Reasons for referral included virological failure (44%), simplification of the current regimen (24%) and antiretroviral drug complications (24%). At latest follow-up, PVC advice had been instituted in 80% of referrals. Suppression following virological failure was achieved in 48% following first referral and 57% following subsequent discussions and was maintained in 95% of children referred for regimen simplification. Following advice, dyslipidaemia resolved in 42% and liver function normalised in 73% with biochemical hepatitis. Adherence support aided resolution of viraemia in nine children and 12% of referrals resulted in additional support, including psychology, social services and mental health input. CONCLUSIONS: Combined multidisciplinary virtual input with adult expertise in resistance and newer agents, paediatric knowledge of pill swallowing, childhood formulations/weight banding and parental support, assists complex treatment decision making in paediatric HIV infection. The Virtual Clinic model could be applied to the management of other rare complex diseases of childhood within a clinical network.


Assuntos
Terapia Antirretroviral de Alta Atividade , Tomada de Decisões , Infecções por HIV/tratamento farmacológico , Comunicação Interdisciplinar , Telemedicina/métodos , Adolescente , Criança , Humanos , Londres , Encaminhamento e Consulta , Estudos Retrospectivos , Falha de Tratamento , Resultado do Tratamento
14.
Plant Cell Environ ; 10(1): 95-101, 1987 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28692161

RESUMO

Stacking of thylakoid membranes in vitro was assessed using electron microscopy. Grana stacks of spinach thylakoids formed when 5 mol m-3 MgCl2 was present, but no stacking of thylakoids from the mangrove Avicennia marina occurred in the presence of 10 mol m-3 ? MgCl2 . Isolation of mangrove thylakoids with a high osmotic strength medium did not induce grana formation if the medium consisted only of sorbitol or glycinebetaine. Addition of cations to the high osmotic strength medium did induce some loose-grana formation, with divalent cations being more effective than monovalent cations. Glycinebetaine was a better osmoticum than sorbitol for grana formation provided divalent cations had been added. Oxygen evolution activity of the preparations was influenced by the amount of membrane stacking, with the preparations with the greatest amount of stacked membrane having the highest activity. Isolation with sorbitol or glycinebetaine based media did not alter this pattern, nor did assay in sorbitol or glycinebetaine. Mangrove thylakoids have a requirement for both a high osmotic strength and divalent cations for grana formation in vitro which may be related to the low water potential of the plant environment in vivo.

15.
Int J STD AIDS ; 11(7): 424-7, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10919482

RESUMO

Post-exposure prophylaxis (PEP) is the standard of care for occupational exposure to HIV infection although it has not been evaluated following non-occupational exposure. Although the most effective methods for preventing HIV infection remain those that prevent exposure to HIV in the first place, this article discusses the dilemmas surrounding post-exposure therapy following non-occupational exposure.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/prevenção & controle , Exposição Ambiental , Ética Médica , Infecções por HIV/tratamento farmacológico , Infecções por HIV/transmissão , Humanos , Fatores de Risco
16.
Sci Total Environ ; 285(1-3): 53-67, 2002 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-11874048

RESUMO

Volatile organic compounds (VOC) are of increasing environmental significance as a result of continually increasing volumes of traffic on European roads. An open-top chamber fumigation system has been devised to investigate how these contaminants transfer between the atmosphere and the ground, and how they partition between and within air-plant-soil systems. Variation in chamber temperature, solar radiation in the chamber and chamber flow rate were identified as factors that affected final air concentrations. These were assessed and quantified for all individual chambers used--effectively characterising each chamber. The real-life VOC concentrations generated were stable and readily reproducible. Grass exposed to benzene, toluene, 1,1,1-trichloroethane and tetrachloroethene, respectively, equilibrated in response to a change in air concentration within hours. The rate of equilibration in exposed grass in all cases was independent of air temperature. 1,1,1-Trichloroethane and tetrachloroethene appear to be biologically inert demonstrating a simple physico-chemical approach to equilibrium, however, benzene and toluene do not appear independent of plant metabolic activity. Aqueous solubility can account for all of the toluene and benzene in the fumigated plant material.


Assuntos
Poluentes Atmosféricos/farmacocinética , Monitoramento Ambiental , Poaceae/fisiologia , Solventes/química , Emissões de Veículos , Exposição Ambiental , Cinética , Compostos Orgânicos/farmacocinética , Solubilidade , Temperatura , Volatilização
17.
Disabil Rehabil ; 18(11): 540-9, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9233851

RESUMO

The ICIDH classification system has had an important effect on many areas of rehabilitation. In this article an application of the handicap category of the ICIDH system within the assessment of aphasia is described. This assessment procedure, Communicative Profiling System, provides an example of how detailed and authentic examination of complex social phenomena can be accomplished. A case study and implications of this procedural application are provided.


Assuntos
Afasia/diagnóstico , Comunicação , Relações Interpessoais , Afasia/psicologia , Afasia/reabilitação , Avaliação da Deficiência , Humanos , Masculino , Pessoa de Meia-Idade
18.
J Speech Lang Hear Res ; 44(3): 624-38, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11407567

RESUMO

This article reports the development and evaluation of a new intervention termed "Supported Conversation for Adults with Aphasia" (SCA). The approach is based on the idea that the inherent competence of people with aphasia can be revealed through the skill of a conversation partner. The intervention approach was developed at a community-based aphasia center where volunteers interact with individuals with chronic aphasia and their families. The experimental study was designed to test whether training improves the conversational skills of volunteers, and, if so, whether the improvements affect the communication of their conversation partners with aphasia. Twenty volunteers received SCA training, and 20 control volunteers were merely exposed to people with aphasia. Comparisons between the groups' scores on a Measure of Supported Conversation for Adults with Aphasia provide support for the efficacy of SCA. Trained volunteers scored significantly higher than untrained volunteers on ratings of acknowledging competence [F(1, 36) = 19. 1, p < .001] and revealing competence [F(1, 36) = 159.0, p < .001] of their partners with aphasia. The training also produced a positive change in ratings of social [F(1, 36) = 5.7, p < .023] and message exchange skills [F(1, 36) = 17.6, p < .001 ] of individuals with aphasia, even though these individuals did not participate in the training. Implications for the treatment of aphasia and an argument for a social model of intervention are discussed.


Assuntos
Afasia/terapia , Experimentação Humana , Fonoterapia/métodos , Ensino , Comportamento Verbal , Humanos , Pessoa de Meia-Idade , Método Simples-Cego
20.
Biotech Histochem ; 86(6): 421-8, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21091080

RESUMO

Tissue microarrays place tens to hundreds of formalin fixed, paraffin embedded tissue cores into a paraffin block in a systematic grid pattern that permits their simultaneous evaluation in a single section. The fragmented nature of the tissue cores often makes sectioning of tissue microarrays difficult so that the resulting disks of tissue lose their shape, fracture or fall out of the paraffin section altogether. We have evaluated an alternative sectioning protocol for stabilizing the tissue microarray surface by placing an adhesive tape "window" over the face of the paraffin block prior to sectioning. Once sectioned, the tape/sections are transferred directly onto coated microscope slides, thereby avoiding routine floating of sections on a water bath. After sectioning with either the tape transfer or standard protocols, slides were stained either using hematoxylin and eosin or immunohistochemistry using antibodies to S-100 protein and the tissue specific antigens, keratin (AE1/3) and the leukocyte common antigen CD45. We found that the tape method produced thicker sections that were darker and more densely packed with loss of tissue definition compared to sections prepared using water bath flotation. Quantitative image analysis of immunohistochemical staining demonstrated that the tape method produced a higher incidence of nonspecific staining, which raised the potential for false positive staining.


Assuntos
Melhoria de Qualidade , Manejo de Espécimes/instrumentação , Análise Serial de Tecidos/instrumentação , Artefatos , Técnicas de Preparação Histocitológica , Imuno-Histoquímica , Microtomia , Inclusão em Parafina/métodos , Controle de Qualidade , Manejo de Espécimes/métodos , Coloração e Rotulagem , Análise Serial de Tecidos/métodos , Inclusão do Tecido/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA